SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-008259
Filing Date
2019-02-07
Accepted
2019-02-07 18:47:03
Documents
2
Period of Report
2019-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2969
2 POA DOCUMENT poa.txt EX-24.3_831231 3084
  Complete submission text file 0001209191-19-008259.txt   7462
Mailing Address C/O CASCADIAN THERAPEUTICS, INC. 3101 WESTERN AVE., SUITE 600 SEATTLE WA 98121
Business Address
EASTLAND JULIA MARIE (Reporting) CIK: 0001500189 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38800 | Film No.: 19576816

Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)